Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
542 questions in 42 reviews · Skin
current versionsNo studies 542 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Chemical peeling vs combined chemical peeling plus any active intervention Quality of life · people with acne scars Interventions for acne scars (2016) · Cochrane | no estimate extracted | NR | No studies |
Chemical peeling vs needling Participant‐reported scar improvement (long‐term) · people with acne scars Interventions for acne scars (2016) · Cochrane | no estimate extracted | NR | No studies |
Chemical peeling vs needling Quality of life · people with acne scars Interventions for acne scars (2016) · Cochrane | no estimate extracted | NR | No studies |
Injectable fillers vs placebo or no treatment Participant‐assessed scar improvement (long‐term) · people with acne scars Interventions for acne scars (2016) · Cochrane | no estimate extracted | NR | No studies |
Injectable fillers vs placebo or no treatment Quality of life · people with acne scars Interventions for acne scars (2016) · Cochrane | no estimate extracted | NR | No studies |
Fractional laser vs non‐fractional non‐ablative laser Participant satisfaction · people with acne scars Interventions for acne scars (2016) · Cochrane | no estimate extracted | NR | No studies |
Fractional laser vs non‐fractional non‐ablative laser Quality of life · people with acne scars Interventions for acne scars (2016) · Cochrane | no estimate extracted | NR | No studies |
Fractional laser vs radiofrequency Participant‐reported scar improvement (long‐term) · people with acne scars Interventions for acne scars (2016) · Cochrane | no estimate extracted | NR | No studies |
Fractional laser vs radiofrequency Investigator‐assessed adverse events (short‐term) · people with acne scars Interventions for acne scars (2016) · Cochrane | no estimate extracted | NR | No studies |
Metronidazole vs placebo HRQOL ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Doxycycline 40 mg + azelaic acid gel vs doxycycline 40 mg + metronidazole gel Clinician's Erythema Assessment ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Doxycycline 40 mg + azelaic acid gel vs doxycycline 40 mg + metronidazole gel Duration of remission ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Minocycline 45 mg vs minocycline 45 mg + azelaic acid gel HRQOL ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Minocycline 45 mg vs minocycline 45 mg + azelaic acid gel Participant‐assessed improvement in rosacea severity ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Minocycline 45 mg vs minocycline 45 mg + azelaic acid gel Duration of remission ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Topical metronidazole vs oral (oxy)tetracycline HRQOL ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Topical metronidazole vs oral (oxy)tetracycline Time needed until improvement ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Topical metronidazole vs oral (oxy)tetracycline Duration of remission ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Low dose isotretinoin 0.3 mg/kg vs doxycycline 50‐100 mg HRQOL ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Low dose isotretinoin 0.3 mg/kg vs doxycycline 50‐100 mg Time needed until improvement ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Low dose isotretinoin 0.3 mg/kg vs doxycycline 50‐100 mg Duration of remission ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Pulsed dye laser vs Nd:YAG laser HRQOL ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Pulsed dye laser vs Nd:YAG laser Physician‐assessed improvement in rosacea severity ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Pulsed dye laser vs Nd:YAG laser Lesion count ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Pulsed dye laser vs Nd:YAG laser Time until improvement ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Pulsed dye laser vs Nd:YAG laser Duration of remission ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Pulsed dye laser vs intense pulsed light therapy HRQOL ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Pulsed dye laser vs intense pulsed light therapy Physician‐assessed improvement in rosacea severity ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Pulsed dye laser vs intense pulsed light therapy Lesion count ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Pulsed dye laser vs intense pulsed light therapy Time until improvement ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Pulsed dye laser vs intense pulsed light therapy Duration of remission ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Azelaic acid vs placebo Duration of remission ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Topical ivermectin vs placebo Assessment of erythema or telangiectasia ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Topical ivermectin vs placebo Duration of remission ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Topical brimonidine vs vehicle HRQOL ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Topical brimonidine vs vehicle Physician‐assessed improvement in rosacea severity ‐ not reported · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Topical brimonidine vs vehicle Lesion count ‐ not reported · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Topical brimonidine vs vehicle Duration of remission ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Topical azelaic acid vs topical metronidazole HRQOL ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Topical azelaic acid vs topical metronidazole Duration of remission ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Topical ivermectin vs topical metronidazole Assessment of erythema or telangiectasia ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Topical ivermectin vs topical metronidazole Duration of remission ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Ciclosporin ophthalmic emulsion 0.05% vs artificial tears Participant‐assessed improvement in rosacea severity ‐ not measured · Participants with ocular rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Ciclosporin ophthalmic emulsion 0.05% vs artificial tears Assessment of erythema or telangiectasia ‐ not measured · Participants with ocular rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Ciclosporin ophthalmic emulsion 0.05% vs artificial tears Lesion count ‐ not measured · Participants with ocular rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Ciclosporin ophthalmic emulsion 0.05% vs artificial tears Time needed until improvement of the skin lesions ‐ not measured · Participants with ocular rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Ciclosporin ophthalmic emulsion 0.05% vs artificial tears Duration of remission ‐ not measured · Participants with ocular rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Clindamycin phosphate 1.2% + tretinoin 0.025% gel vs placebo Participant‐assessed improvement in rosacea severity ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Clindamycin phosphate 1.2% + tretinoin 0.025% gel vs placebo Time needed until improvement of the skin lesions ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Clindamycin phosphate 1.2% + tretinoin 0.025% gel vs placebo Duration of remission ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |